If a clinically suspected SMA patient has only a single copy of SMN1, it is likely that the remaining copy contains an SNV, which requires gene sequencing (Prior et al., 2011; Wirth et al., 2020). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.